In vitro neutralizing activity of BNT162b2 mRNA-induced antibodies against full B.1.351 SARS-CoV-2 variant

Artículo original

Año: 2022

Serrano-Conde, E; Leyva, A; Fuentes, A; de Salazar, A; Chueca, N; Perez-Castro, S; Regueiro, B; Rojas, A; Mendoza, J; Rojas, J; Garcia, F

Título: TRANSBOUNDARY AND EMERGING DISEASES

• D1